Cardiff Oncology, Inc.
CRDF· Nasdaq
CRDFCardiff Oncology, Inc.
Filed May 14, 2013 · 10-Q · 44 days after period end · 0001104659-13-041327
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $119.00K | $34.00K | $89.08K |
| Net Income | -$1.11M | -$1.16M | -$551.99K |
| EPS Diluted | -$0.07 | -$0.11 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 14, 2013 · 44 d after period end
